BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Immunic Highlights Extended Data from EMPhASIS Trial in Peer-Reviewed Journal Vidofludimus Calcium EMPhASIS Trial Relapsing-remitting Multiple Sclerosis Neuroprotection Immune Modulation
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Immunic présente des données étendues de l'essai EMPhASIS dans une revue à comité de lecture Vidofludimus Calcium Neuroprotection Essai EMPhASIS Sclérose En Plaques Rémittente Modulation Immunitaire
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Zomedica to Present Q1 2024 Financial Results and Business Update on May 9th Financial Results Conference Call Business Update Zomedica Q1 2024
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Zomedica présentera ses résultats financiers du premier trimestre 2024 et une mise à jour de ses activités le 9 mai Résultats Financiers Zomedica Conférence Téléphonique Mise À Jour De L'entreprise T1 2024
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago IFabric Corp Achieves FDA Medical Device Registration for Innovative Apparel Medical Device Healthcare Innovation FDA Registration Apparel Technology Textile Technology
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago IFabric Corp obtient l'enregistrement d'un dispositif médical par la FDA pour des vêtements innovants Innovation En Matière De Soins De Santé Dispositif Médical Enregistrement Auprès De La FDA Technologie Du Vêtement Technologie Textile
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Planet 13 Introduces New MEDIZIN Branded Topical Products Cannabis Industry Planet 13 Invisicare Technology MEDIZIN Topicals CBT Hemp
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago Planet 13 présente de nouveaux produits topiques de marque MEDIZIN Industrie Du Cannabis Planète 13 Technologie Invisicare Topiques MEDIZIN Chanvre CBT
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago NanoViricides Announces Successful Completion of Phase I Clinical Trial for NV-387 NanoViricides NV-387 Phase I Clinical Trial Antiviral Treatment RSV Infection
BRIEF published on 04/30/2024 at 12:35, 2 years 5 months ago NanoViricides annonce la réussite de l'essai clinique de phase I pour le NV-387 NanoViricides NV-387 Essai Clinique De Phase I Traitement Antiviral Infection Par Le VRS
Published on 10/14/2026 at 15:40, 5 hours 28 minutes ago Galway Metals Announces Closing of $14 Million Brokered Private Placement Led by Michael Gentile
Published on 10/14/2026 at 15:00, 6 hours 8 minutes ago Route1 Provides Operating and Market Update; Outlines Q4 2026 Priorities
Published on 10/14/2026 at 15:00, 6 hours 8 minutes ago Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Published on 10/14/2026 at 14:50, 6 hours 18 minutes ago AIAI Holdings to Present at the 20th Annual LD Micro Main Event
Published on 10/14/2026 at 14:30, 6 hours 38 minutes ago Boron One Holdings Inc. Announces Positive Preliminary Economic Assessment (PEA) for Its Piskanja Boron Project
Published on 10/14/2026 at 19:32, 1 hour 35 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year – net sales up – forecast confirmed
Published on 10/14/2026 at 19:05, 2 hours 2 minutes ago Bulgin Introduces 6000 Series Hybrid Buccaneer Connectors for Power and Signal Connectivity
Published on 10/14/2026 at 19:00, 2 hours 7 minutes ago Informations relatives à l’augmentation de capital
Published on 10/14/2026 at 18:43, 2 hours 24 minutes ago Jean-Marc Bellaiche to become new CEO of the DOUGLAS Group - Sander van der Laan to retire
Published on 10/14/2026 at 18:00, 3 hours 8 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 3 hours 8 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
Published on 10/14/2026 at 17:40, 3 hours 28 minutes ago Mersen obtient la certification internationale Living Wage pour son engagement en faveur du bien-être de ses collaborateurs
Published on 10/14/2026 at 17:40, 3 hours 28 minutes ago Mersen’s commitment to employee well-being earns it international Living Wage certification
